IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0271587.html
   My bibliography  Save this article

Barriers and facilitators to pharmacovigilance activities in Pakistan: A healthcare professionals-based survey

Author

Listed:
  • Rabia Hussain
  • Tayyaba Akram
  • Mohamed Azmi Hassali
  • Jaya Muneswarao
  • Anees ur Rehman
  • Furqan Hashmi
  • Zaheer-Ud-Din Babar

Abstract

The timely reporting of adverse drug reactions (ADRs) could improve pharmacovigilance (PV) in a healthcare system. However, in almost all healthcare systems barriers exist that lead to the underreporting of ADRs. The objective of this study was to identify the barriers and facilitators regarding PV activities from the point of view of healthcare professionals (HCPs) in Lahore, Pakistan. A cross-sectional questionnaire-based survey was conducted between September 2018 to January 2019. The data was collected through convenience sampling of physicians, pharmacists, and nurses at tertiary care public hospitals in Lahore. A total of 384 questionnaires were distributed, and 346 HCPs responded to the survey. Over 62% percent of physicians and 54.8% of nurses agreed that they did not know how to report an ADR in their workplace. About 43.2% of pharmacists and 40.1% of nurses disagreed that they were not aware of the need for ADR reporting. Furthermore, 41.6% of nurses identified a lack of financial reimbursement and 51.8% highlighted a lack of support from a colleague as a reason that could lead to the underreporting of ADR. The majority of participants, including 69.6% physicians, 48.6% pharmacists, and 55.3% nurses identified the lack of knowledge about the existence of a national PV centre. Extra time for ADR reporting, incentives, continuous medical education, reminders, and availability of an online ADR reporting system was classed as the facilitators and were agreed upon by the majority of HCPs.

Suggested Citation

  • Rabia Hussain & Tayyaba Akram & Mohamed Azmi Hassali & Jaya Muneswarao & Anees ur Rehman & Furqan Hashmi & Zaheer-Ud-Din Babar, 2022. "Barriers and facilitators to pharmacovigilance activities in Pakistan: A healthcare professionals-based survey," PLOS ONE, Public Library of Science, vol. 17(7), pages 1-15, July.
    • Handle: RePEc:plo:pone00:0271587
    DOI: 10.1371/journal.pone.0271587
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0271587
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0271587&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0271587?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Rabia Hussain & Mohamed Azmi Hassali & Anees ur Rehman & Jaya Muneswarao & Furqan Hashmi, 2020. "Physicians’ Understanding and Practices of Pharmacovigilance: Qualitative Experience from a Lower Middle-Income Country," IJERPH, MDPI, vol. 17(7), pages 1-15, March.
    2. Agnieszka Zimmermann & Agata Flis & Aleksandra Gaworska–Krzemińska & Marsha N Cohen, 2020. "Drug-safety reporting in Polish nursing practice—Cross sectional surveys," PLOS ONE, Public Library of Science, vol. 15(10), pages 1-13, October.
    3. Yun Mi Yu & Euni Lee & Bon Sun Koo & Kyeong Hye Jeong & Kyung Hee Choi & Lee Kyung Kang & Mo Se Lee & Kwang Hoon Choi & Jung Mi Oh & Wan Gyoon Shin, 2016. "Predictive Factors of Spontaneous Reporting of Adverse Drug Reactions among Community Pharmacists," PLOS ONE, Public Library of Science, vol. 11(5), pages 1-13, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Joanne Barnes & Rachael Butler, 2020. "Community Pharmacists’ Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand," Drug Safety, Springer, vol. 43(11), pages 1157-1170, November.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0271587. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.